Peer-influenced content. Sources you trust. No registration required. This is HCN.

EP Lab DigestElectrical Cardioversion for Atrial Fibrillation in the Modern Era

A Spanish cohort study of 243 AF patients undergoing elective cardioversion found 93% acute success but only 40% sinus rhythm maintenance at one year, mirroring outcomes from decades ago. A fortuitously captured patch monitor recording reveals that most patients experience transient arrhythmias post-conversion, not clean sinus restoration.


Clinical Considerations

  • Long-term cardioversion success remains low at 40% by one year, reinforcing catheter ablation as the more durable rhythm control strategy.
  • Average wait time to cardioversion was 265 days, likely long enough for atrial remodeling to undermine procedural success.
  • Amiodarone use predicted sinus rhythm maintenance; surprisingly, left atrial size and delay to cardioversion did not reach significance in this cohort.
  • Post-conversion bradycardia and transient arrhythmias are common and expected, not signs of procedural failure.

Practice Applications

  • Refer persistent symptomatic AF patients for cardioversion promptly, without waiting for electrophysiology consultation.
  • Schedule cardioversion plus TEE as a combined procedure to reduce access delays for anticoagulation-ineligible patients.
  • Counsel patients that cardioversion success rates at one year are approximately 40%, setting realistic expectations.
  • Consider catheter ablation earlier when cardioversion fails or AF recurs, rather than repeat electrical conversion alone.

More in Atrial Fibrillation

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form